Description:

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Keywords:
Versions (4) ▾
  1. 10/5/17
  2. 2/22/18
  3. 2/22/18
  4. 2/22/18
Copyright Holder:
gsk
Uploaded on:

February 22, 2018

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Ropinirole Case Report Form GSK RRL100013

INVESTIGATIONAL PRODUCT

Investigational Product